- Home
- ONEW vs ADCT Comparison
ONEW vs ADCT Comparison
Compare ONEW & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONEW
- ADCT
- Stock Information
- Founded
- ONEW 2014
- ADCT 2011
- Country
- ONEW United States
- ADCT Switzerland
- Employees
- ONEW N/A
- ADCT N/A
- Industry
- ONEW Auto & Home Supply Stores
- ADCT Biotechnology: Pharmaceutical Preparations
- Sector
- ONEW Consumer Discretionary
- ADCT Health Care
- Exchange
- ONEW Nasdaq
- ADCT Nasdaq
- Market Cap
- ONEW 318.6M
- ADCT 224.3M
- IPO Year
- ONEW 2020
- ADCT 2020
- Fundamental
- Price
- ONEW $18.59
- ADCT $2.12
- Analyst Decision
- ONEW Buy
- ADCT Strong Buy
- Analyst Count
- ONEW 5
- ADCT 5
- Target Price
- ONEW $29.00
- ADCT $8.00
- AVG Volume (30 Days)
- ONEW 104.5K
- ADCT 1.7M
- Earning Date
- ONEW 01-30-2025
- ADCT 11-07-2024
- Dividend Yield
- ONEW N/A
- ADCT N/A
- EPS Growth
- ONEW N/A
- ADCT N/A
- EPS
- ONEW N/A
- ADCT N/A
- Revenue
- ONEW $1,772,630,000.00
- ADCT $70,717,000.00
- Revenue This Year
- ONEW $3.74
- ADCT $6.58
- Revenue Next Year
- ONEW $5.06
- ADCT $11.78
- P/E Ratio
- ONEW N/A
- ADCT N/A
- Revenue Growth
- ONEW N/A
- ADCT N/A
- 52 Week Low
- ONEW $17.62
- ADCT $1.45
- 52 Week High
- ONEW $34.90
- ADCT $6.04
- Technical
- Relative Strength Index (RSI)
- ONEW 39.09
- ADCT 46.65
- Support Level
- ONEW $17.62
- ADCT $1.93
- Resistance Level
- ONEW $21.40
- ADCT $2.18
- Average True Range (ATR)
- ONEW 1.05
- ADCT 0.41
- MACD
- ONEW -0.24
- ADCT -0.01
- Stochastic Oscillator
- ONEW 20.00
- ADCT 18.64
About ONEW OneWater Marine Inc.
OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segment- Dealerships and Distribution. Its dealer groups are located throughout the Southeast, Gulf Coast, Mid-Atlantic, and Northeast. The company's revenue profile is comprised of new boat sales, pre-owned boat sales, finance and insurance products, repair and maintenance services, and parts and accessories. Majority of revenue is generated from sale of new boats.
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.